139 related articles for article (PubMed ID: 37269441)
1. Under-reporting of gastrointestinal bleeding associated with anticoagulant use using the UK Yellow Card Scheme.
Shuttleworth P; Baker J; Clark E
Int J Clin Pharm; 2023 Aug; 45(4):1014-1018. PubMed ID: 37269441
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
3. Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK.
Thompson A; Randall C; Howard J; Barker C; Bowden D; Mooney P; Munyika A; Smith S; Pirmohamed M
J Clin Pharm Ther; 2019 Feb; 44(1):78-83. PubMed ID: 30206951
[TBL] [Abstract][Full Text] [Related]
4. Interpreting adverse drug reaction (ADR) reports as hospital patient safety incidents.
Davies EC; Green CF; Mottram DR; Pirmohamed M
Br J Clin Pharmacol; 2010 Jul; 70(1):102-8. PubMed ID: 20642552
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.
Mokbel K; Daniels R; Weedon MN; Jackson L
In Vivo; 2022; 36(2):780-800. PubMed ID: 35241534
[TBL] [Abstract][Full Text] [Related]
6. Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme.
O' Donovan B; Rodgers RM; Cox AR; Krska J
Br J Clin Pharmacol; 2022 Jul; 88(7):3434-3446. PubMed ID: 35128732
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database.
Barbieri MA; Cutroneo PM; Baratelli C; Cicala G; Battaglia A; Santoro V; Andò G; Spina E
J Clin Pharm Ther; 2021 Aug; 46(4):1027-1040. PubMed ID: 33646603
[TBL] [Abstract][Full Text] [Related]
9. Relevance of physicochemical properties and functional pharmacology data to predict the clinical safety profile of direct oral anticoagulants.
Ferro CJ; Solkhon F; Jalal Z; Al-Hamid AM; Jones AM
Pharmacol Res Perspect; 2020 Jun; 8(3):e00603. PubMed ID: 32500654
[TBL] [Abstract][Full Text] [Related]
10. The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK.
Klein K; Hazell L; Stolk P; Shakir S
Drug Saf; 2020 Mar; 43(3):255-263. PubMed ID: 31872358
[TBL] [Abstract][Full Text] [Related]
11. How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.
Hazell L; Cornelius V; Hannaford P; Shakir S; Avery AJ;
Drug Saf; 2013 Mar; 36(3):199-206. PubMed ID: 23444232
[TBL] [Abstract][Full Text] [Related]
12. Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports.
Schifano N; Chiappini S; Castiglione F; Salonia A; Schifano F
Low Urin Tract Symptoms; 2021 Apr; 13(2):230-237. PubMed ID: 33037767
[TBL] [Abstract][Full Text] [Related]
13. Assessing and further developing age-appropriate information for young people about reporting suspected adverse drug reactions.
Bioletti L; ; Woodward C; Jadeja M; Hawcutt DB
Br J Clin Pharmacol; 2024 Mar; 90(3):863-870. PubMed ID: 37990602
[TBL] [Abstract][Full Text] [Related]
14. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.
Rehan HS; Chopra D; Holani SN; Mishra R
Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346
[TBL] [Abstract][Full Text] [Related]
15. Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions.
Bracchi RC; Tseliou F; Copeland L; Routledge PA; Thomas A; Woods F; Adams A; Walker J; Jadeja M; Atkinson MD; Ashfield-Watt P
Br J Clin Pharmacol; 2021 Aug; 87(8):3344-3348. PubMed ID: 33386761
[TBL] [Abstract][Full Text] [Related]
16. How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.
Krska J; Anderson C; Murphy E; Avery AJ
Drug Saf; 2011 May; 34(5):429-36. PubMed ID: 21513365
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance.
Moudallel S; van den Eynde C; Malý J; Rydant S; Steurbaut S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1143-1153. PubMed ID: 36656352
[TBL] [Abstract][Full Text] [Related]
18. [Under-reporting of adverse drug reactions, a problem that also involves medicines subject to additional monitoring. Preliminary data from a single-center experience on novel oral anticoagulants].
Patrignani A; Palmieri G; Ciampani N; Moretti V; Mariani A; Racca L
G Ital Cardiol (Rome); 2018 Jan; 19(1):54-61. PubMed ID: 29451510
[TBL] [Abstract][Full Text] [Related]
19. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
[TBL] [Abstract][Full Text] [Related]
20. Reported paediatric adverse drug reactions in the UK 2000-2009.
Hawcutt DB; Mainie P; Riordan A; Smyth RL; Pirmohamed M
Br J Clin Pharmacol; 2012 Mar; 73(3):437-46. PubMed ID: 21988288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
